🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.
UPGRADE TO SEE LIVE SIGNALS
$TSHA
Taysha Gene Therapies Inc
FREE PREVIEW
AVG HISTORICAL GAP12.16%
MAX GAP RECORD105.68%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY15.3%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL